Inhalation Therapy for Lung Diseases: A Comprehensive Review of Pulmonary Drug Delivery Systems
DOI:
https://doi.org/10.22270/ajprd.v13i2.1531Abstract
Inhalation therapy has become a popular method for treating respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). The lungs are the primary organs responsible for gas exchange, and inhalation therapy provides a direct route for drug delivery. Various pulmonary drug delivery systems, including metered-dose inhalers, dry powder inhalers, and nebulizers, have been developed to improve the efficacy of inhalation therapy. These systems utilize various carriers, such as liposomes, nanoparticles, and microspheres, to deliver drugs directly to the lungs, enhancing efficacy and reducing systemic side effects. This review provides a comprehensive overview of the different types of pulmonary drug delivery systems, their advantages and disadvantages, and their applications in treating various lung diseases. The article also discusses the role of nanotechnology in pulmonary drug delivery and the potential benefits of using nanoparticles for targeted drug delivery.
Downloads
References
Borghardt JM, Kloft C, Sharma A. Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes. Can Respir J. 2018 Jun 19;2018:2732017. doi: 10.1155/2018/2732017. PMID: 30018677; PMCID: PMC6029458.
Forest V, Pourchez J. Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient? Adv Drug Deliv Rev. 2022 Apr;183:114173. doi: 10.1016/j.addr.2022.114173. Epub 2022 Feb 22. PMID: 35217112. Page 1-55.
Madhavan P, Farzana Rizwan, and Imam Shaik. Immuno-Pathogenesis of RespiratoryDiseases, P. Madhavan et al. 2021;1-46.
Chan Y, Ng SW, Liew HS, Wei Pua LJ, Soon L, Lim JS, Dua K, Chellappan DK. Introduction to Chronic Respiratory Diseases: A Pressing Need for Novel Therapeutic Approaches,Medicinal Plants for Lung Diseases. 2021;47-84.
OviaM,Yasasve M, Ansel Vishal L.Role of Indian Herbal Medicine in the Treatment of Pulmonary Diseases, Medicinal Plants for Lung Diseases. 2021;85-102.
Shaheen S, Jaffer M. Medicinal Plants in Targeting Asthma, S. Medicinal Plants for Lung Diseases. 2021;101-150.
Sonawane G, Mishra S, Rawat S, Rawat S, Pathak S, Singh SK, Gupta G, Gilhotra R. Incipient Need of Medicinal Plants in Targeting Chronic Obstructive Pulmonary Disease, G. B. Medicinal Plants for Lung Diseases. 2021;151-168.
Koirala N, Modi B, Subba RK, Panthi M, Xiao J. Medicinal Plants in Targeting Tuberculosis II,N. Medicinal Plants for Lung Diseases. 2021;185-215.
Dhiman A, Dureja H. Exploring the Potential of Medicinal Plants in Lung Cancer, Medicinal Plants for Lung Diseases. 2021;157-284.
Smola M, Vandamme T, Sokolowski A. Nanocarriers as pulmonary drug delivery systems totreat and to diagnose respiratory and non Respiratory diseases, International Journal of Nanomedicine. 2008:3(1) 1–19.
Zaidur M, Sabuj R, Islam N. Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections, Royal Society of Chemistry,NanoscaleAdvances. 2021;(14);1-15.
Roy A, dean R. Aerosol Delivery Devices for Obstructive Lung Diseases,Respiratory Care.2018;63:708-733.
Ibrahim M, Verma R, Garciacontreras L. Inhalation drug delivery devices: technology Update, Medical Devices: Evidence and Research. 2015;8 :131–139.10.2147/MDER.S48888
Kaur R, Kaur R, Singh C, Kaur S, Goyal AK, Singh KK, Singha B. Inhalational Drug Delivery in Pulmonary Aspergillosis, Therapeutic Drug Carrier Systems.2019;36(3):183–217.
McCarthy SD, González HE, Higgins BD. Future Trends in Nebulized Therapies for Pulmonary Disease. J Pers Med. 2020 May 10;10(2):37.
Fahad, Ahmed S, Formulation and evaluation of paclitaxel-loaded nanoemulsion for pulmonary administration. University of Toledo. Theses and Dissertations. 2017.
Rogliani P, Calzetta L, Coppola A, Cavalli F, Ora J, Puxeddu E, Matera MG, Cazzola M. Optimizing drug delivery in COPD: The role of inhaler devices. Respir Med. 2017 Mar;124:6-14. 2017 Jan 24. PMID: 28284323, 6-14.
Lavorini F, Mannini C, Chellini E, Fontana GA. Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices. Drugs Aging. 2016 Jul;33(7):461-73.
Chan JG, Wong J, Zhou QT, Leung SS, Chan HK. Advances in device and formulation technologies for pulmonary drug delivery. AAPS PharmSciTech. 2014 Aug;15(4):882-97.
Bobe KR. Advances in Pulmonary Drug Delivery Strategies, Challenges, and Emerging Technologies for Treating Respiratory Diseases, Integrated Publications. 2024;1-16.
Alipour S, Mahmoudi L, Ahmadi F. Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19. Drug Deliv Transl Res. 2023 Mar;13(3):705-715.
Shaikh MSH, Hatwar PR, Bakal RL and Kohale NB. A comprehensive review on Liposomes: As a novel drug delivery system. GSC Biological and Phamaceutical Sciences, 2024;27(01), 199-210.
Virmani T, Kumar G, Virmani, Sharma RA, Pathak K. Xanthan Gum-Based Drug Delivery Systems for Respiratory Diseases, Natural Polymeric Materials based Drug Delivery Systemsin Lung Diseases, 2023;279-295.
Baig MS, Karade SK, Ahmad A, Khan MA, Haque A, Webster TJ, Faiyazuddin M, Al-Qahtani NH. Lipid-based nanoparticles: innovations in ocular drug delivery. Front Mol Biosci. 2024 Sep 17;11:1421959.
Mehanna MM, Mohyeldin SM, Elgindy NA. Respirable nanocarriers as a promising strategy for antitubercular drug delivery. J Control Release. 2014 Aug 10;187:183-97.
Dukovski BJ, Mrak L,Winnicka K, Szekalska M, Juretić M, Filipović-Grčić J,Pepić I,Lovrić J, Hafner A. Spray-dried nanoparticle-loaded pectin Microspheres for dexamethasone nasal delivery,Drying Technology. 2019;37(15):1915–1925.
Mehtaa M, Sharmaa P, Kaurd S, Singh DS, Singh P, Vyasa M, Gupta G, Chellappan DK, Nammi S, Singh TG, Duab K,Satijaa S. Plant-based drug delivery Systems in respiratory Diseases, Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. 2020;1(1):517-539.
Lukhele BS, Bassey K, Witika BA. The Utilization of Plant-Material-Loaded Vesicular Drug Delivery Systems in the Management of Pulmonary Diseases, Curr. Issues Mol. Biol. 2023;45(12):9985–10017.
Menezes BR, Rodrigues KF, Schatkoski VM, Pereira RM, Ribas RG, Montanheiro TL, Thim GP. Current advances in drug delivery of nanoparticles For respiratory disease treatment,J. Mater. Chem. B. 2021;9, 1745-1761.
Lim PN, Cervantes MM, Pham LK, Rothchild AC. Alveolar macrophages: novel therapeutic targets for respiratory diseases. Expert Rev Mol Med. 2021 Nov 26;23:e18.
Benedikter BJ, Wouters EFM, Savelkoul PHM, Rohde GGU, Stassen FRM. Extracellular vesicles released in response to respiratory exposures: implications for chronic disease. J Toxicol Environ Health B Crit Rev. 2018;21(3):142-160.
Jin X, Song L,Ma CC, Zhang YC, Yu S. Pulmonary route of administration is instrumental in developing Therapeutic interventions against respiratory diseases, Saudi Pharm J. 2022;11:30(5):646.
Rosita N,Kalalo T, Miatmoko A, Pathak Y, Hariyadi DM. Microspheres for inhalation delivery (characteristics and in vitro release),International Journal of Medical Reviews and Case Reports.2022;6(2):24-31.
Miranda MS, Rodrigues MT, Domingues RMA, Torrado E, Reis RL, Pedrosa J, Gomes ME. Exploring inhalable polymeric dry powders for anti-tuberculosis drug delivery. Mater Sci Eng C Mater Biol Appl. 2018 Dec 1;93:1090-1103.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Gaurav P.Aswar, Pooja R. Hatwar, Dr. Ravindra L. Bakal, Gopal R.sonone, Om N.Ajmire
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.